Human Periosteal Derived Stem Cell Potential: The Impact of age

Stem Cell Reviews and Reports

Volumn 11, Issue 3, 2015, Pages 487-500

  Ferretti, Concetta ^a   Lucarini, Guendalina ^a   Andreoni, Chiara ^b   Salvolini, Eleonora ^a   Bianchi, Novella ^a   Vozzi, Giovanni ^b   Gigante, Antonio ^a   Mattioli Belmonte, Monica ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b UNIVERSITY OF PISA   (Italy)

Author keywords

Age related; Ki67; Mathematical modelling; Nitric Oxide; p53; Periosteal cells; qRT PCR

Indexed keywords

BETA GLUCURONIDASE; BONE MORPHOGENETIC PROTEIN 2; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; INTERLEUKIN 6; KI 67 ANTIGEN; MESSENGER RNA; NITRIC OXIDE; OCTAMER TRANSCRIPTION FACTOR 4; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; PROTEIN P53; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR RUNX2; TRANSCRIPTION FACTOR SOX2;

ADOLESCENT; ADULT; ARTICLE; BONE AGE; BONE REMODELING; CELL AGING; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL RENEWAL; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DOWN REGULATION; FLOW CYTOMETRY; GENE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MATHEMATICAL ANALYSIS; METABOLIC BONE DISEASE; MIDDLE AGED; OSTEOBLAST; PERIOSTEUM; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REGENERATIVE MEDICINE; RNA EXTRACTION; SIMULATION; STEM CELL; UPREGULATION; VERY ELDERLY; AGING; BIOSYNTHESIS; BONE DISEASE; CYTOLOGY; FEMALE; GENE EXPRESSION REGULATION; GENETICS; MALE; MESENCHYMAL STROMA CELL; METABOLISM; PATHOLOGY;

ADOLESCENT; ADULT; AGED, 80 AND OVER; AGING; BONE DISEASES; CELL DIFFERENTIATION; FEMALE; GENE EXPRESSION REGULATION; HUMANS; KI-67 ANTIGEN; MALE; MESENCHYMAL STROMAL CELLS; MIDDLE AGED; NITRIC OXIDE; OSTEOBLASTS; PERIOSTEUM; REGENERATIVE MEDICINE; RNA, MESSENGER; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84930651358     PISSN: 15508943     EISSN: 15586804     Source Type: Journal    
DOI: 10.1007/s12015-014-9559-3     Document Type: Article

References (58)

1. Zaidi, M. (2007). Skeletal remodeling in health and disease. Nature Medicine, 13, 791–801.
2. Rodriguez, J. P., Rios, S., Fernandez, M., & Santibañez, J. F. (2004). Differential activation of ERK1,2MAP Kinase signaling pathway in mesenchymal stem cell from control and osteoporotic postmenopausal women. Journal of Cellular Biochemistry, 92, 745–754.
3. Martin, T. J., & Sims, N. A. (2005). Osteoclast-derived activity in the coupling of bone formation to resorption. Trends in Molecular Medicine, 11, 76–81.
4. Leskelä, H. V., Risteli, J., Niskanen, S., Koivunen, J., Ivaska, K. K., & Lehenkari, P. (2003). Osteoblast recruitment from stem cells does not decrease by age at late adulthood. Biochemical and Biophysical Research Communications, 311, 1008–1013.
5. Caplan, A. I. (2005). Mesenchymal stem cells: cell-based reconstructive therapy in orthopedics. Tissue Engineering, 11, 1198–1211.
6. Veronesi, F., Torricelli, P., Borsari, V., Tschon, M., Rimondini, L., & Fini, M. (2011). Mesenchymal stem cells in the aging and osteoporotic population. Critical Reviews in Eukaryotic Gene Expression, 21, 363–377.
7. Hayflick, L. (1965). The limited in vitro lifetime of human diploid cell strains. Experimental Cell Research, 37, 614–636.
8. Bullwinkel, J., Baron-Lühr, B., Lüdemann, A., Wohlenberg, C., Gerdes, J., & Scholzen, T. (2006). Ki-67 protein is associated with ribosomal RNA transcription in quiescent and proliferating cells. Journal of Cellular Physiology, 206, 624–635.
9. Lawless, C., Wang, C., Jurk, D., Merz, A., Zglinicki, T. V., & Passos, J. F. (2010). Quantitative assessment of markers for cell senescence. Experimental Gerontology, 45, 772–778. doi:10.1016/j.exger.2010.01.018.
10. Yan, X., Ehnert, S., Culmes, M., et al. (2014). 5-azacytidine improves the osteogenic differentiation potential of aged human adipose-derived mesenchymal stem cells by DNA demethylation. PLoS One, 6, e90846. doi:10.1371/journal.pone.0090846.
11. Kasper, G., Mao, L., Geissler, S., et al. (2009). Insights into mesenchymal stem cell aging: involvement of antioxidant defense and actin cytoskeleton. Stem Cells, 27, 1288–1297. doi:10.1002/stem.49.
12. Stenderup, K., Justesen, J., Clausen, C., & Kassem, M. (2003). Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells. Bone, 33, 919–926.
13. Zhou, S., Greenberger, J. S., Epperly, M. W., et al. (2003). Age-related intrinsic changes in human bone marrow-derived mesenchymal stem cells and their differentiation to osteoblasts. Aging Cell, 7, 335–343. doi:10.1111/j.1474-9726.2008.00377.x.
14. Stolzing, A., Jones, E., McGonagle, D., & Scutt, A. (2008). Age-related changes in human bone marrow-derived mesenchymal stem cells: consequences for cell therapies. Mechanisms of Ageing and Development, 129, 163–173. doi:10.1016/j.mad.2007.12.002.
15. Abdallah, B. M., Haack-Sørensen, M., Fink, T., & Kassem, M. (2006). Inhibition of osteoblast differentiation but not adipocyte differentiation of mesenchymal stem cells by sera obtained from aged females. Bone, 39, 181–188.
16. Astudillo, P., Rios, S., Pastenes, L., Pino, A. M., & Rodríguez, J. P. (2008). Increased adipogenesis of osteoporotic human-mesenchymal stem cells (MSCs) is characterized by impaired leptin action. Journal of Cellular Biochemistry, 103, 1054–1065.
17. Jiang, Y., Mishima, H., Sakai, S., Liu, Y. K., Ohyabu, Y., & Uemura, T. (2008). Gene expression analysis of major lineage-defining factors in human bone marrow cells: effect of aging, gender, and age-related disorders. Journal of Orthopaedic Research, 26, 910–917. doi:10.1002/jor.20623.
18. Chang, H., & Knothe Tate, M. L. (2012). Concise review: the periosteum: tapping into a reservoir of clinically useful progenitor cells. Stem Cells Translational Medicine, 1, 480–491. doi:10.5966/sctm.2011-0056.
19. Gentile, P., Mattioli-Belmonte, M., Chiono, V., et al. (2012). Bioactive glass/polymer composite scaffolds mimicking bone tissue. Journal of Biomedical Materials Research. Part A, 100, 2654–2667. doi:10.1002/jbm.a.34205.
20. Ringe, J., Leinhase, I., Stich, S., et al. (2008). Human mastoid periosteum-derived stem cells: promising candidates for skeletal tissue engineering. Journal of Tissue Engineering and Regenerative Medicine, 2, 136–146. doi:10.1002/term.75.
21. Colnot, C. (2009). Skeletal cell fate decisions within periosteum and bone marrow during bone regeneration. Journal of Bone and Mineral Research, 24, 274–282. doi:10.1359/jbmr.081003.
22. Zhang, X., Xie, C., Lin, A. S., et al. (2005). Periosteal progenitor cell fate in segmental cortical bone graft transplantations: implications for functional tissue engineering. Journal of Bone and Mineral Research, 20, 2124–2137.
23. Zhang, X., Awad, H. A., O’Keefe, R. J., Guldberg, R. E., & Schwarz, E. M. (2008). A perspective: engineering periosteum for structural bone graft healing. Clinical Orthopaedics and Related Research, 466, 1777–1787. doi:10.1007/s11999-008-0312-6.
24. Chen, L., & Wu, J. (2012). Editorial: systems biology for complex disease. Journal of Molecular Cell Biology, 4, 125–126. doi:10.1093/jmcb/mjs022.
25. Ferretti, C., Borsari, V., Falconi, M., et al. (2012). Human periosteum-derived stem cells for tissue engineering applications: the role of VEGF. Stem Cell Reviews, 8, 882–890. doi:10.1007/s12015-012-9374-7.
26. Ferretti, C., Vozzi, G., Falconi, M., et al. (2014). Role of IGF1 and IGF1/VEGF on Human Mesenchymal Stromal Cells (HMSCs) in bone healing: two sources two fates. Tissue Engineering Part A. doi:10.1089/ten.tea.2013.0453.
27. Dominici, M., Le Blanc, K., Mueller, I., et al. (2006). Minimal criteria for deifying multipotent mesenchymal stem cells. The international society for cellular therapy position statement. Cytotherapy, 8, 315–317.
28. Gerdes, J., Schwab, U., Lemke, H., & Stein, H. (1983). Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. International Journal of Cancer, 31, 13–20.
29. Ragni, E., Viganò, M., Rebulla, P., Giordano, R., & Lazzari, L. (2013). What is beyond a qRT-PCR study on mesenchymal stem cell differentiation properties: how to choose the most reliable housekeeping genes. Journal of Cellular and Molecular Medicine, 17, 168–180. doi:10.1111/j.1582-4934.2012.01660.x.
30. Livak, K. J., & Schmittgen, T. D. (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)). Method Methods, 25, 402–408.
31. Orsi, G., De Maria, C., Guzzardi, M., Vozzi, F., & Vozzi, G. (2011). HEMETβ: improvement of hepatocyte metabolism mathematical model. Computer Methods in Biomechanics and Biomedical Engineering, 14, 837–851. doi:10.1080/10255842.2010.497145.
32. Van’t Hof, R. J., & Ralston, S. H. (2001). Nitric oxide and bone. Immunology, 103, 255–261.
33. Colnot, C., Zhang, X., & Knothe Tate, M. L. (2012). Current insights on the regenerative potential of the periosteum: molecular, cellular, and endogenous engineering approaches. Journal of Orthopaedic Research, 30, 1869–1878. doi:10.1002/jor.22181.
34. McBride, S. H., Evans, S. F., & Knothe Tate, M. L. (2011). Anisotropic mechanical properties of ovine femoral periosteum and the effects of cryopreservation. Journal of Biomechanics, 44, 1954–1959. doi:10.1016/j.jbiomech.2011.04.036.
35. Ferretti, C., & Mattioli-Belmonte, M. (2014). Periosteum derived stem cells for regenerative medicine proposals: boosting current knowledge. World Journal Stem Cells, 6(3), 266–277. doi:10.4252/wjsc.v6.i3.266.
36. Moore, S. R., Milz, S., & Knothe Tate, M. L. (2014). Periosteal thickness and cellularity in mid-diaphyseal cross-sections from human femora and tibiae of aged donors. Journal of Anatomy, 224, 142–149. doi:10.1111/joa.12133.
37. Byun, C. H., Koh, J. M., Kim, D. K., Park, S. I., Lee, K. U., & Kim, G. S. (2005). Alpha-lipoic acid inhibits TNF-alpha-induced apoptosis in human bone marrow stromal cells. Journal of Bone and Mineral Research, 20, 1125–1135.
38. Johnson, W. E., Eisenstein, S. M., & Roberts, S. (2001). Cell cluster formation in degenerate lumbar intervertebral discs is associated with increased disc cell proliferation. Connect Tissue Reserch, 42, 197–207.
39. Burova, E., Borodkina, A., Shatrova, A., & Nikolsky, N. (2013). Sublethal oxidative stress induces the premature senescence of human mesenchymal stem cells derived from endometrium. Oxidative Medicine and Cellular Longevity, 2013, 474931. doi:10.1155/2013/474931.
40. Fortini, C., Cesselli, D., Beltrami, A. P., et al. (2014). Alteration of Notch signaling and functionality of adipose tissue derived mesenchymal stem cells in heart failure. International Journal of Cardiology, 174, 119–126. doi:10.1016/j.ijcard.2014.03.173.
41. Hermann, A., List, C., Habisch, H. J., et al. (2010). Age-dependent neuroectodermal differentiation capacity of human mesenchymal stromal cells: limitations for autologous cell replacement strategies. Cytotherapy, 12, 17–30. doi:10.3109/14653240903313941.
42. Correia-Melo, C., Jurk, D., & Passos, J. F. (2013). Robust multiparametric assessment of cellular senescence. Methods in Molecular Biology, 965, 409–419. doi:10.1007/978-1-62703-239-1_27.
43. Korotchkina, L. G., Leontieva, O. V., Bukreeva, E. I., Demidenko, Z. N., Gudkov, A. V., & Blagosklonny, M. V. (2010). The choice between p53-induced senescence and quiescence is determined in part by the mTOR pathway. Aging, 2, 344–352.
44. Feng, Z., Lin, M., & Wu, R. (2011). The regulation of aging and longevity: a new complex role of p53. Genes & Cancer, 2, 443–452. doi:10.1177/1947601911410223.
45. Leontieva, O. V., & Blagosklonny, M. V. (2014). M(o)TOR of pseudo-hypoxic state in aging: rapamycin to the rescue. Cell Cycle, 13, 509–515. doi:10.4161/cc.27973.
46. Campisi, J. (2005). Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors. Cell, 120, 513–522.
47. Wang, X., Kua, H. Y., Hu, Y., et al. (2006). p53 functions as a negative regulator of osteoblastogenesis, osteoblast-dependent osteoclastogenesis, and bone remodeling. Journal of Cell Biology, 172, 115–125.
48. Choi, B. M., Pae, H. O., Jang, S. I., Kim, Y. M., & Chung, H. T. (2002). Review: nitric oxide as a pro-apoptotic as well as anti-apoptotic modulator. Journal of Biochemistry and Molecular Biology, 35, 116–126.
49. Tebbi, A., Guittet, O., Cottet, M. H., Vesin, M. F., & Lepoivre, M. (2011). TAp73 induction by nitric oxide: regulation by checkpoint kinase 1 (CHK1) and protection against apoptosis. Journal of Biological Chemistry, 286, 7873–7884. doi:10.1074/jbc.M110.184879.
50. Ho, W. P., Chan, W. P., Hsieh, M. S., & Chen, R. M. (2009). Runx2-mediated bcl-2 gene expression contributes to nitric oxide protection against hydrogen peroxide-induced osteoblast apoptosis. Journal of Cellular Biochemistry, 108, 1084–1093. doi:10.1002/jcb.22338.
51. Marcellini, S., Henriquez, J. P., & Bertin, A. (2012). Control of osteogenesis by the canonical Wnt and BMP pathways in vivo: cooperation and antagonism between the canonical Wnt and BMP pathways as cells differentiate from osteochondroprogenitors to osteoblasts and osteocytes. Bioessays, 34, 953–962. doi:10.1002/bies.201200061.
52. Kaltz, N., Funari, A., Hippauf, S., et al. (2008). In-vivo osteoprogenitor potency of human stromal cells from different tissues does not correlate with expression of POU5F1 or its pseudogenes. Stem Cells, 26, 2419–2424. doi:10.1634/stemcells.2008-0304.
53. Lengner, C. J., Camargo, F. D., Hochedlinger, K., et al. (2007). Oct4 expression is not required for mouse somatic stem cell self-renewal. Cell Stem Cell, 1, 403–415.
54. Beltrami, A. P., Cesselli, D., Bergamin, N., et al. (2007). Multipotent cells can be generated in vitro from several adult human organs (heart, liver and bone marrow). Blood, 110, 3438–3446.
55. Greco, S. J., Liu, K., & Rameshwar, P. (2007). Functional similarities among genes regulated by OCT4 in human mesenchymal and embryonic stem cells. Stem Cells, 25, 3143–3154.
56. Pierantozzi, E., Gava, B., Manini, I., Roviello, F., Marotta, G., Chiavarelli, M., & Sorrentino, V. (2011). Pluripotency regulators in human mesenchymal stem cells: expression of NANOG but not of OCT-4 and SOX-2. Stem Cells and Development, 20, 915–923. doi:10.1089/scd.2010.0353.
57. Basu-Roy, U., Ambrosetti, D., Favaro, R., Nicolis, S. K., Mansukhani, A., & Basilico, C. (2010). The transcription factor Sox2 is required for osteoblast self-renewal. Cell Death and Differentiation, 17, 1345–1353. doi:10.1038/cdd.2010.57.
58. Yoon, D. S., Kim, Y. H., Lee, S., Lee, K. M., Park, K. H., Jang, Y., & Lee, J. W. (2014). Interleukin-6 induces the lineage commitment of bone marrow-derived mesenchymal multipotent cells through down-regulation of Sox2 by osteogenic transcription factors. FASEB Journal, 28, 3273–3286. doi:10.1096/fj.13-248567.